Cargando…

Adipose Tissue-Derived Components: From Cells to Tissue Glue to Treat Dermal Damage

In recent decades, adipose tissue transplantation has become an essential treatment modality for tissue (volume) restoration and regeneration. The regenerative application of adipose tissue has only recently proven its usefulness; for example, the method is useful in reducing dermal scarring and acc...

Descripción completa

Detalles Bibliográficos
Autores principales: Vriend, Linda, van der Lei, Berend, Harmsen, Martin C., van Dongen, Joris A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045962/
https://www.ncbi.nlm.nih.gov/pubmed/36978719
http://dx.doi.org/10.3390/bioengineering10030328
_version_ 1785013546957930496
author Vriend, Linda
van der Lei, Berend
Harmsen, Martin C.
van Dongen, Joris A.
author_facet Vriend, Linda
van der Lei, Berend
Harmsen, Martin C.
van Dongen, Joris A.
author_sort Vriend, Linda
collection PubMed
description In recent decades, adipose tissue transplantation has become an essential treatment modality for tissue (volume) restoration and regeneration. The regenerative application of adipose tissue has only recently proven its usefulness; for example, the method is useful in reducing dermal scarring and accelerating skin-wound healing. The therapeutic effect is ascribed to the tissue stromal vascular fraction (tSVF) in adipose tissue. This consists of stromal cells, the trophic factors they secrete and the extracellular matrix (ECM), which have immune-modulating, pro-angiogenic and anti-fibrotic properties. This concise review focused on dermal regeneration using the following adipose-tissue components: adipose-tissue-derived stromal cells (ASCs), their secreted trophic factors (ASCs secretome), and the ECM. The opportunities of using a therapeutically functional scaffold, composed of a decellularized ECM hydrogel loaded with trophic factors of ASCs, to enhance wound healing are explored as well. An ECM-based hydrogel loaded with trophic factors combines all regenerative components of adipose tissue, while averting the possible disadvantages of the therapeutic use of adipose tissue, e.g., the necessity of liposuction procedures with a (small) risk of complications, the impossibility of interpatient use, and the limited storage options.
format Online
Article
Text
id pubmed-10045962
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100459622023-03-29 Adipose Tissue-Derived Components: From Cells to Tissue Glue to Treat Dermal Damage Vriend, Linda van der Lei, Berend Harmsen, Martin C. van Dongen, Joris A. Bioengineering (Basel) Review In recent decades, adipose tissue transplantation has become an essential treatment modality for tissue (volume) restoration and regeneration. The regenerative application of adipose tissue has only recently proven its usefulness; for example, the method is useful in reducing dermal scarring and accelerating skin-wound healing. The therapeutic effect is ascribed to the tissue stromal vascular fraction (tSVF) in adipose tissue. This consists of stromal cells, the trophic factors they secrete and the extracellular matrix (ECM), which have immune-modulating, pro-angiogenic and anti-fibrotic properties. This concise review focused on dermal regeneration using the following adipose-tissue components: adipose-tissue-derived stromal cells (ASCs), their secreted trophic factors (ASCs secretome), and the ECM. The opportunities of using a therapeutically functional scaffold, composed of a decellularized ECM hydrogel loaded with trophic factors of ASCs, to enhance wound healing are explored as well. An ECM-based hydrogel loaded with trophic factors combines all regenerative components of adipose tissue, while averting the possible disadvantages of the therapeutic use of adipose tissue, e.g., the necessity of liposuction procedures with a (small) risk of complications, the impossibility of interpatient use, and the limited storage options. MDPI 2023-03-05 /pmc/articles/PMC10045962/ /pubmed/36978719 http://dx.doi.org/10.3390/bioengineering10030328 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Vriend, Linda
van der Lei, Berend
Harmsen, Martin C.
van Dongen, Joris A.
Adipose Tissue-Derived Components: From Cells to Tissue Glue to Treat Dermal Damage
title Adipose Tissue-Derived Components: From Cells to Tissue Glue to Treat Dermal Damage
title_full Adipose Tissue-Derived Components: From Cells to Tissue Glue to Treat Dermal Damage
title_fullStr Adipose Tissue-Derived Components: From Cells to Tissue Glue to Treat Dermal Damage
title_full_unstemmed Adipose Tissue-Derived Components: From Cells to Tissue Glue to Treat Dermal Damage
title_short Adipose Tissue-Derived Components: From Cells to Tissue Glue to Treat Dermal Damage
title_sort adipose tissue-derived components: from cells to tissue glue to treat dermal damage
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045962/
https://www.ncbi.nlm.nih.gov/pubmed/36978719
http://dx.doi.org/10.3390/bioengineering10030328
work_keys_str_mv AT vriendlinda adiposetissuederivedcomponentsfromcellstotissuegluetotreatdermaldamage
AT vanderleiberend adiposetissuederivedcomponentsfromcellstotissuegluetotreatdermaldamage
AT harmsenmartinc adiposetissuederivedcomponentsfromcellstotissuegluetotreatdermaldamage
AT vandongenjorisa adiposetissuederivedcomponentsfromcellstotissuegluetotreatdermaldamage